COVID-19: Thrombosis, Coagulopathy and Disseminated Intravascular Coagulation

Guidelines: Practical guidance for the prevention of thrombosis and management of coagulopathy and disseminated intravascular coagulation of patients infected with COVID-19 – Thrombosis UK AND ISTH interim guidance on recognition and management of coagulopathy – Journal of Thrombosis and Haemostasis

Observational Studies: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy – Journal of Thrombosis and Haemostasis AND Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia – Journal of Thrombosis and Haemostasis (free PDF)

Q & A: COVID-19 and Coagulopathy: Frequently Asked Questions – American Society of Hematology